Point72 Hong Kong’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,763
Closed -$154K 465
2025
Q1
$154K Buy
+4,763
New +$177K 0.01% 319
2024
Q2
Sell
-1,003
Closed -$30.5K 453
2024
Q1
$30.5K Buy
+1,003
New +$33.6K ﹤0.01% 477
2022
Q4
Sell
-1,489
Closed -$58K 187
2022
Q3
$58K Sell
1,489
-173
-10% -$7.92K ﹤0.01% 1386
2022
Q2
$68K Buy
+1,662
New +$78.7K ﹤0.01% 1286
2021
Q4
Sell
-1,172
Closed -$82K 1877
2021
Q3
$82K Sell
1,172
-4
-0.3% -$308 ﹤0.01% 1397
2021
Q2
$93K Buy
+1,176
New +$85.5K ﹤0.01% 1335
2020
Q3
Sell
-944
Closed -$42K 1184
2020
Q2
$42K Buy
944
+60
+7% +$2.61K ﹤0.01% 763
2020
Q1
$30K Buy
884
+704
+391% +$25.3K 0.01% 459
2019
Q4
$6K Buy
180
+141
+362% +$4.01K ﹤0.01% 1031
2019
Q3
$1K Buy
+39
New +$1.11K ﹤0.01% 892

Other funds holding ATRC

Point72 Hong Kong's ATRC Position: Q2 2025 in Review

Point72 Hong Kong sold out of AtriCure (ATRC) in Q2 2025, closing a stake of 4,763 shares — an estimated $154K sold.

Point72 Hong Kong first reported a position in ATRC in Q3 2019 and held it in 10 quarters. The position peaked at $154K in Q1 2025. 201 funds tracked by Wall St. Rank hold ATRC as of Q2 2025.

  • Point72 Hong Kong reported no remaining AtriCure position as of Q2 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 4,763 AtriCure shares in Q2 2025, an estimated $154K.
  • Point72 Hong Kong first reported a position in AtriCure in Q3 2019 and held it in 10 quarters.
  • Point72 Hong Kong's AtriCure position peaked at $154K in Q1 2025.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q2 2025.

Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.